{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-016676","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.078679+00:00","generated_at":"2026-06-14T06:20:32.976855+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"LeMaitre Vascular announces 2023 annual meeting voting results","bullets":["Bridget A. Ross elected as Class II director with 14,649,999.71 votes for, 4,496,976 withheld.","John A. Roush elected as Class II director with 18,526,479.71 votes for, 620,496 withheld.","Advisory vote on executive compensation approved: 18,603,555.38 for, 524,894 against.","Ratification of Grant Thornton LLP as auditor for 2023 approved: 20,105,297.71 for, 92,675 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-016676","json":"https://secwatch.observer/filing/0001437749-23-016676.json","markdown":"https://secwatch.observer/filing/0001437749-23-016676.md","text":"https://secwatch.observer/filing/0001437749-23-016676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923016676/0001437749-23-016676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923016676/lmat20230605_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:20:32.976855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"67ac71a088869043cb140d02e4862a5fa45f7f7f","claim":"LEMAITRE VASCULAR INC shareholders approved Ratification of the appointment of Grant Thornton LLP as independent registered public accounting firm for 2023 at the 2023-06-01 meeting.","evidence_excerpt":"Proposal No. 3 – Ratification of the Selection of Independent Registered Public Accounting Firm By a majority of votes cast, the stockholders ratified the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023 with a vote of 20,105,297.71shares for and 92,675 shares against, with 3,262 shares abstaining.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923016676/0001437749-23-016676-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"},{"claim_id":"cc8a1c59fa2d6121714c0a6f5deb30a475f4d981","claim":"LEMAITRE VASCULAR INC shareholders approved Election of two Class II directors at the 2023-06-01 meeting.","evidence_excerpt":"Proposal No. 1 – Election of Directors By a majority of votes cast, the stockholders elected the following two nominees as Class II directors for a term of three years expiring upon the 2026 Annual Meeting of Stockholders or until their successor has been duly elected and qualified. Bridget A. Ross received a vote of 14,649,999.71 shares for, 4,496,976 shares withheld and 1,054,259 broker non-votes. John A. Roush received a vote of 18,526,479.71 shares for, 620,496 shares withheld and 1,054,259 broker non-votes.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923016676/0001437749-23-016676-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"},{"claim_id":"d13e98c369b7923b51be62dfa1766b93a24469f2","claim":"LEMAITRE VASCULAR INC shareholders approved Advisory vote on executive compensation at the 2023-06-01 meeting.","evidence_excerpt":"Proposal No. 2 – Advisory Vote on Executive Compensation By a majority of votes cast, the stockholders approved, on an advisory basis, the Company's executive compensation by a vote of 18,603,555.38 shares for and 524,894 shares against, with 18,526.33 shares abstaining and 1,054,259 broker non-votes.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000143774923016676/0001437749-23-016676-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}